Elanco Animal Health ELAN
NYSE ELAN
$23.86 -0.64 (-2.61%)
At close: Aug 20, 2026 · 12:00 PM UTC

Elanco Animal Health (ELAN) Total Debt Growth (3y) (2021 - 2026)

Elanco Animal Health (ELAN) Total Debt Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (3y) (Qtr)
1 Haleon 44.05 Bn 43.08 Bn - 15.43%
2 Teva Pharmaceutical Industries 43.39 Bn 39.74 Bn 2.15 Bn -7.08%
3 Zoetis 31.86 Bn 30.18 Bn 1.05 Bn 11.33%
4 Takeda Pharmaceutical 28.78 Bn 22.99 Bn 5.10 Bn -3.67%
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn -
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn -10.43%
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn -
8 Elanco Animal Health 11.92 Bn 11.39 Bn 798.00 Mn -13.72%
9 Dr Reddys Laboratories 10.16 Bn 9.99 Bn - 92.83%
10 Alkermes 8.17 Bn 7.51 Bn 397.90 Mn 72.66%

Historic Data

Download Data
DateValue
Jun 30, 2026 -13.72%
Mar 31, 2026 -14.15%
Dec 31, 2025 -13.05%
Sep 30, 2025 -13.86%
Jun 30, 2025 -11.46%
Mar 31, 2025 -10.81%
Dec 31, 2024 -13.22%
Sep 30, 2024 -11.71%
Jun 30, 2024 -11.99%
Mar 31, 2024 -5.20%
Dec 31, 2023 -4.54%
Sep 30, 2023 1.82%
Jun 30, 2023 43.14%
Mar 31, 2023 42.34%
Dec 31, 2022 35.32%
Sep 30, 2022 323.46%
Jun 30, 2022 313.27%
Mar 31, 2022 35.95%
Dec 31, 2021 38.28%
Sep 30, 2021 115.96%